2 withdrawn, 1 active not recruiting, 1 completed, 1 recruiting. 4 Phase 1, 1 Early Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Withdrawn 2, Active not recruiting 1, Recruiting 1 |
| Early Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Malignant Neoplasms of Mesothelial and Soft Tissue: new trials by email Literature Review of Malignant Neoplasms of Mesothelial and Soft Tissue trials Research Report on Malignant Neoplasms of Mesothelial and Soft Tissue
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Doxorubicin and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Intraoperative Brachytherapy for Unresectable or Refractory Pelvic and Abdominal Rhabdomyosarcoma and Undifferentiated Sarcomas in Children Abdominal Surgery, Doxorubicin, Intra-Operative Radiation - Malignant Neoplasms of Mesothelial and Soft Tissue, Rhabdomyosarcoma, Pelvic | Phase 1 | Withdrawn | M.D. Anderson Cancer Center | 2018-08-01 | 2018-07-20 | |
| Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT Pembrolizumab, Clostridium Novyi-NT, Doxycycline - Malignant Neoplasm of Breast, Malignant Neoplasms of Digestive Organs | Phase 1 | Active not recruiting | M.D. Anderson Cancer Center | 18 | 2018-07-10 | 2026-04-16 |
| Efficacy of Ferric Carboxymaltose in Gastrointestinal Stromal Tumor (GIST) Patients With Iron Deficiency Anemia (IDA) Receiving Systemic Therapy Ferric Carboxymaltose, Iron Supplements, Questionnaire - Malignant Neoplasms of Mesothelial and Soft Tissue, Gastrointestinal Stromal Tumor With Neurogenic Differentiation | Phase 2 | Terminated | M.D. Anderson Cancer Center | 3 | 2017-12-18 | 2020-04-06 |
| Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases Gemcitabine - Malignant Neoplasm of Bone and Articular Cartilage, Malignant Neoplasms of Female Genital Organs | Phase 1 | Recruiting | M.D. Anderson Cancer Center | 44 | 2017-11-22 | 2026-07-15 |
| Lenvatinib and Capecitabine in Patients With Advanced Malignancies Lenvatinib, Capecitabine - Advanced Cancer, Malignant Neoplasm of Breast | Phase 1 | Withdrawn | M.D. Anderson Cancer Center | 2016-12-01 | 2017-06-26 | |
| Non Invasive Oral Cancer Screening Among HIV Infected Individuals Screening Interview, Carbon Monoxide Test, Self-Help Materials - Malignant Neoplasms of Mesothelial and Soft Tissue, Human Immunodeficiency Virus | Early Phase 1 | Completed | M.D. Anderson Cancer Center | 44 | 2016-06-30 | 2022-02-14 |
Urologic Neoplasms (3) · Breast Neoplasms (2) · Abdominal Neoplasms (1) · Acquired Immunodeficiency Syndrome (1) · Anemia, Iron-Deficiency (1) · Bone Neoplasms (1) · Gastrointestinal Stromal Tumors (1) · Melanoma (1) · Osteosarcoma (1) · Plexosarcoma (1) · Rhabdomyosarcoma (1)
Neoplasms (5) · Neoplasms by Site (4) · Urogenital Diseases (4) · Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Male Urogenital Diseases (3) · Neoplasms by Histologic Type (3) · Neoplasms, Connective and Soft Tissue (3) · Skin Diseases (3) · Skin and Connective Tissue Diseases (3) · Urogenital Neoplasms (3) · Urologic Diseases (3) · Breast Diseases (2) · Neoplasms, Connective Tissue (2) · Sarcoma (2)
Biopsy (1) · Capecitabine (1) · Doxorubicin (1) · Doxycycline (1) · Gemcitabine (1) · Iron-Dextran Complex (1) · Surveys and Questionnaires (1) · ferric carboxymaltose (1) · lenvatinib (1) · pembrolizumab (1)
M.D. Anderson Cancer Center (6)
United States (4)
Andrea Hayes-Jordan, MD (1) · David S. Hong, MD (1) · Irene M. Tami-Maury, DRPH (1) · Najat C. Daw-Bitar, MD (1) · Sarina Piha-Paul, MD (1) · Sarina Piha-Paul, MD, PHD (1) · Saroj Vadhan-Raj, MD (1)